December 2, 2021
Ruben A. Mesa, MD, FACP, executive director of the Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, has played a key role as both an investigator and aiding the drug development for the past eight years to get RoPEG INFa2b (besremi) approved in PV.
November 29, 2021
Yoga improved physical and mental well-being and promoted a robust immune response in a randomized clinical trial of men with prostate cancer.
UT Health San Antonio researchers planning clinical trial of potential Parkinson’s disease treatment
November 23, 2021
Researchers at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) are working towards the first human clinical trial of a novel treatment for Parkinson’s disease. The new approach, published in Molecular Therapy in 2020, solves two pieces of the puzzle that have prevented previous treatments from working. The new […]
November 19, 2021
In partnership with UT Health San Antonio, Be Well Texas, a new statewide addiction medicine treatment option, has launched virtual services for those seeking recovery from substance use disorders and mental health challenges.
November 18, 2021
It’s a medical conundrum. Ionizing radiation, which at first extends the survival of glioblastoma patients after surgery, may later, ironically, help drive the brain cancer’s aggressive, untreatable recurrence. Dr. Sandeep Burma and a team of investigators at the Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, are studying companion treatments to see if any can eliminate this Jekyll and Hyde property of ionizing radiation.
November 11, 2021
Mansour M. Zadeh, PhD, from The University of Texas Health Science Center at San Antonio (UT Health San Antonio) has been awarded a $1.5 million award from The UT System.